Health Minister Discretionary Grant
Under Health Minister’s Discretionary Grant (HMDG) financial assistance up to a maximum of Rs. 1.25 lakhs are provided to the poor indigent patients to defray a part of the expenditure on hospitalization/treatment in Government Hospitals for life threatening diseases covered under Rashtriya Arogya Nidhi (RAN) in cases where free medical facilities are not available. Only […]
Medical Colleges Set Up Under CSS's
The Ministry of Health & Family Welfare administers a Centrally Sponsored Scheme (CSS) for “Establishment of new medical colleges attached with existing district/referral hospitals”. Establishment of 157 new Medical Colleges has been approved under the scheme in three phases. Out of these 157 medical colleges, 47 have become functional. Another 36 medical colleges have applied […]
Joint statement by UNICEF Executive Director Henrietta Fore and WHO Director-General Dr. Tedros Adhanom Ghebreyesus on the occasion of World Breastfeeding Week
NEW YORK/GENEVA, 2 August 2021 – At the start of this year, governments, donors, civil society and the private sector united to launch the Nutrition for Growth Year of Action. The Year of Action is a historic opportunity to transform the way the world tackles the global commitment to eliminate child malnutrition. Breastfeeding is central […]
Centre rushes High Level team to Maharashtra to support the State in effective public health interventions for Zika
Union Ministry of Health & Family Welfare has rushed a multidisciplinary team to Maharahstra to monitor the Zika virus situation and support the State government in management of Zika cases. A case of Zika has been reported in Pune district recently. The three member Central team consists of a public health expert from the office […]
Healthcare Facilities in Tribal, Backward Areas and SLUMS
To address the healthcare challenges, particularly in rural areas, the National Rural Health Mission (NRHM) was launched in 2005 to supplement the efforts of the State/UT Governments to provide accessible, affordable and quality healthcare to all those who access public health facilities including tribal, backward, slum areas. Currently, NRHM is a sub-mission of National Health […]
2.27 lakh Pregnant Women receive COVID-19 Vaccines in less than a month
In a significant development, over 2.27 lakh pregnant women have received first dose of COVID-19 vaccine under the ongoing National COVID Vaccination drive. This can be seen as a result of regular counseling of the pregnant women by health workers and medical officers about risks of COVD-19 infection to pregnant women and benefits of COVID-19 […]
Stem Cell Research
The Government of India has undertaken stem cell research through various Departments/ Institutions. Department of Health Research-Indian Council of Medical Research (DHR-ICMR) is supporting biomedical research and stem cell is one of the priority areas promoted through centres for advance research/excellence, task force activities in identified thematic areas, viz. Basic stem cell biology, Cancer stem […]
New Medical Colleges
As per information from National Medical Commission (NMC), 90 medical colleges have been established during the last three years. State/UT-wise details are as below: 1 Arunachal PradeshTomoRiba Institute of Health & Medical Sciences, Narahlagun2 MizoramMizoram Institute of Medical Sciences Education & Research, Falkawn, Mizoram3 Himachal PradeshDr. Radhakrishnan Government Medical College, Hamirpur, Himachal Pradesh4 Madhya PradeshGovt. […]
Data for Roche’s Evrysdi® (risdiplam) published in New England Journal of Medicine shows significant improvement in survival and motor milestones in babies with Type 1 spinal muscular atrophy (SMA)
FIREFISH Part 2 study showed treatment with Evrysdi helped babies stay free of permanent ventilation, sit without support and improve across a range of motor milestones Evrysdi has proven efficacy in adults, children and babies two months and older with over 4,000 patients treated to date SMA is the leading genetic cause of death in […]
FDA accepts application for Roche’s faricimab for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME)
Across four phase III studies, approximately half of patients receiving faricimab could extend treatment time to every four months – the first time this level of durability has been achieved in phase III nAMD and DME studies If approved, faricimab would be the first and only medicine designed to target two distinct pathways that drive […]
